Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glutamine and TGF-beta 2 for Prevention of Chemotherapy Side Effects in GI Cancer
NCT00455247Phase 3Completed
- Sponsor
- Nestlé
- Start
- Oct 2007
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in chemotherapy-induced toxicity, sponsored by Nestlé. Started Oct 2007; status: completed.
02
Drugs
glutamine
03
Conditions
chemotherapy-induced toxicity
Beyond the preview
Go deeper on NCT00455247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455247.